Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.
Last trade$0.3467
Day change+$0.0444 (+14.69%)
Day range$0.25 – $0.519
Volume60,744,931
Market cap$4M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for BMGL.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for BMGL.
Recent news
Company coverage with links to the original publishers.
Basel Medical Group Ltd (BMGL) announced on July 10, 2026 that it has regained compliance with Nasdaq's minimum bid price rule of $1.00 per share. The company had been notified of non-compliance in January 2026 but successfully maintained the required minimum closing bid price for 10 consecutive business days from June 23-July 7, 2026.
Basel Medical Group Ltd (Nasdaq: BMGL), a Singapore-based medical clinic operator, announced a 1-for-12 reverse stock split effective June 22, 2026, to comply with Nasdaq's minimum bid price requirement of $1 per share. The consolidation will reduce outstanding shares from approximately 18.8 million to 1.6 million shares.
Basel Medical Group, a Singapore-based healthcare provider, has completed the acquisition of Bethesda Medical, a leading Singapore-based healthcare provider. The acquisition aims to strengthen Basel Medical Group's presence in Singapore and the broader Southeast Asian healthcare market.
Basel Medical Group, a Singapore-based healthcare provider, has signed an agreement to acquire Bethesda Medical, a leading diagnostic imaging and outpatient care provider in Singapore. The acquisition aims to strengthen Basel Medical's presence in the Singapore and Southeast Asian healthcare market.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.